P.11.15 Recombinant human insulin-like growth factor-I (IGF-I) therapy in Duchenne Muscular Dystrophy (DMD): A 6-month prospective randomized controlled trial von Rutter, M.M, Collins, J, Backeljauw, P.F, Horn, P, Taylor, M.D, Hu, S.Y, Blum, S, Morehart, P, Sawnani, H, Wong, B.L

Volltext

Supplementary Material for: Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like... von Backeljauw, P.F., Kuntze, J., Frane, J., Calikoglu, A.S., Chernausek, S.D.

Volltext bestellen

Supplementary Material for: Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Gr... von Backeljauw, P.F., Miller, B.S., Dutailly, P., Houchard, A., Lawson, E., Hale, D.E., Reiner, B., Sperling, M.A.

Volltext bestellen

Supplementary Material for: Expanding Genetic and Functional Diagnoses of IGF1R Haploinsufficiencies von Ocaranza, P., Golekoh, M.C., Andrew, S.F., Guo, M.H., Kaplowitz, P., Saal, H., Rosenfeld, R.G., Dauber, A., Cassorla, F., Backeljauw, P.F., Hwa, V.

Volltext bestellen

Successful weight loss with protein-sparing modified fast in a morbidly obese boy with panhypopituitarism, diabetes insipidus, and defective thirst regulation von Lee, Y.J, Backeljauw, P.F, Kelly, P.D, Verdi, P.D, Redmond, G.P

Volltext